Page last updated: 2024-09-02

fingolimod hydrochloride and Molluscum Contagiosum

fingolimod hydrochloride has been researched along with Molluscum Contagiosum in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Berger, JR; Do, D; Fuller, R; Schneider, S	1
Behle, V; Goebeler, M; Stoevesandt, J; Wobser, M	1

Other Studies

2 other study(ies) available for fingolimod hydrochloride and Molluscum Contagiosum

Article	Year
Molluscum contagiosum in the setting of Fingolimod: The experience at one institution. Multiple sclerosis and related disorders, 2022, Volume: 58 Topics: AIDS-Related Opportunistic Infections; Fingolimod Hydrochloride; Humans; Molluscum Contagiosum	2022
Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod. Multiple sclerosis (Houndmills, Basingstoke, England), 2016, Volume: 22, Issue:7 Topics: Adolescent; Biopsy; Fingolimod Hydrochloride; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Molluscum Contagiosum; Molluscum contagiosum virus; Multiple Sclerosis, Relapsing-Remitting; Opportunistic Infections; Risk Factors	2016

Article

Year

Molluscum contagiosum in the setting of Fingolimod: The experience at one institution.

Multiple sclerosis and related disorders, 2022, Volume: 58

Topics: AIDS-Related Opportunistic Infections; Fingolimod Hydrochloride; Humans; Molluscum Contagiosum

2022

Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod.

Multiple sclerosis (Houndmills, Basingstoke, England), 2016, Volume: 22, Issue:7

Topics: Adolescent; Biopsy; Fingolimod Hydrochloride; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Molluscum Contagiosum; Molluscum contagiosum virus; Multiple Sclerosis, Relapsing-Remitting; Opportunistic Infections; Risk Factors

2016